Sfoglia per Autore
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion
2010-01-01 Defina, M.; Rondoni, M.; Gozzetti, A.; Aprile, L.; Chitarrelli, I.; Fabbri, A.; Lauria, F.; Bocchia, M.
Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia
2010-01-01 Gozzetti, A.; Crupi, R.; Rondoni, M.; Daviddi, B.; Defina, M.; Bocchia, M.; Pietrini, A.; Raspadori, D.; Lauria, F.
Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib
2010-01-01 Defina, M.; Gozzetti, A.; Rondoni, M.; Aprile, L.; Ippoliti, M.; Chitarrelli, I.; Lauria, F.; Bocchia, M.
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
2009-01-01 D., Rossi; M., Cerri; C., Deambrogi; E., Sozzi; S., Cresta; S., Rasi; L. D., Paoli; V., Spina; V., Gattei; D., Capello; Forconi, Francesco; Lauria, Francesco; G., Gaidano
Combination therapies to improve the long-term outcome in hairy cell leukemia.
2009-01-01 Lauria, Francesco; Forconi, Francesco
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
2009-01-01 Else, Monica; Dearden, Claire E.; Matutes, Estella; Garcia‐talavera, Juan; Rohatiner, Ama Z. S.; Johnson, Steve A. N.; O’Connor, Nigel T. J.; Haynes, Andy; Osuji, Nnenna; Forconi, Francesco; Lauria, Francesco; Catovsky, Daniel
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.
2009-01-01 Forconi, Francesco; E., Sozzi; E., Cencini; F., Zaja; T., Intermesoli; C., Stelitano; L., Rigacci; F., Gherlinzoni; R., Cantaffa; A., Baraldi; A., Gallamini; A., Zaccaria; A., Pulsoni; M., Gobbi; M., Tassi; D., Raspadori; Leoncini, Lorenzo; A., Rinaldi; E., Sabattini; F., Bertoni; S. A., Pileri; Lauria, Francesco
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial
2009-01-01 Bocchia, M.; Defina, M.; Ippoliti, M.; Amabile, M.; Breccia, M.; Iuliano, F.; Vignetti, M.; Gugliotta, G.; RUSSO ROSSI, A.; Alimena, A.; Aprile, L.; Gaidano, G.; Nicoli, N.; Trawinska, M. M.; Bassan, R.; Turri, D.; Cannella, L.; Luciano, L.; Gozzetti, A.; Rondoni, M.; Rosti, G.; Martinelli, G.; Baccarani, M.; Lauria, F.
Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia.
2008-01-01 Forconi, F; Sozzi, E; Rossi, D; Sahota, S S; Amato, T; Raspadori, D; Trentin, L; Leoncini, L; Gaidano, G; Lauria, F
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
2008-01-01 Forconi, Francesco; Poretti, Giulia; Kwee, Ivo; Sozzi, Elisa; Rossi, Davide; Rancoita, Paola M. V.; Capello, Daniela; Rinaldi, Andrea; Zucca, Emanuele; Raspadori, Donatella; Spina, Valeria; Lauria, Francesco; Gaidano, Gianluca; Bertoni, Francesco
CMLVAX100 Peptide Vaccinations induce Peptide Specific "cytotoxic" CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response
2008-01-01 Bocchia, M.; Tassi, M.; Ippoliti, M.; Defina, M.; Abruzzese, E.; Trawinska, M. M.; Gozzetti, A.; Raspadori, D.; Lauria, F.
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases
2008-01-01 Malagola, M; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Leoncini, L; Paolini, S; DE ROSA, Federica; Lauria, F.; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Priccolo, G; Gugliotta, L; Bonini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, Am; Filì, C; Fanin, R; Baccarani, M; Russo, D
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion
2008-01-01 Forconi, Francesco; Rinaldi, Andrea; Kwee, Ivo; Sozzi, Elisa; Raspadori, Donatella; Rancoita, Paola M. V.; Scandurra, Marta; Rossi, Davide; Deambrogi, Clara; Capello, Daniela; Zucca, Emanuele; Marconi, Daniela; Bomben, Riccardo; Gattei, Valter; Lauria, Francesco; Gaidano, Gianluca; Bertoni, Francesco
Reply to “Rituximab activity in CD20-positive multiple myeloma”
2008-01-01 Gozzetti, Alessandro; Fabbri, Annalisa; Lazzi, Stefano; Bocchia, Monica; Lauria, Francesco
Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia
2008-01-01 Forconi, Francesco; Fabbri, Alberto; Lenoci, Mariapia; Sozzi, Elisa; Gozzetti, Alessandro; Tassi, Maristella; Raspadori, Donatella; Lauria, Francesco
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis
2008-01-01 Cavazzini, Francesco; Hernandez, Jose Angel; Gozzetti, Alessandro; Russo Rossi, Antonella; De Angeli, Cristiano; Tiseo, Ruana; Bardi, Antonella; Tammiso, Elisa; Crupi, Rosaria; Lenoci, Maria Pia; Forconi, Francesco; Lauria, Francesco
The effects of zoledronic acid on serum lipids in multiple myeloma patients
2008-01-01 Gozzetti, A.; Gennari, L.; Merlotti, D.; Salvadori, S.; DE PAOLA, V.; Avanzati, A.; Franci, B.; Marchini, E.; Tozzi, M.; Campagna, M. S.; Nuti, R.; Lauria, F.; Martini, G.
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate
2008-01-01 Bocchia, Monica; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pirrotta, Mt; Crupi, R; Tozzuoli, D; Trawinska, Mm; Defina, M; Martinelli, G; Lauria, Francesco
Promyelocytic blast crisis of chronic myelogenous leukaemia during imatinib treatment.
2007-01-01 Gozzetti, A; Bocchia, M; Calabrese, S; Pirrotta, M. T; Crupi, R; Raspadori, D; Lauria, F.
Deletion 9q in a patient with concomitant myelodisplasia and non-Hodgkin lymphoma
2007-01-01 Gozzetti, A.; Calabrese, S.; Crupi, R.; Tozzuoli, D.; Fabbri, A.; Bocchia, M.; Pirrotta, M. T.; Defina, M.; Lauria, F.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion | 1-gen-2010 | Defina, M.; Rondoni, M.; Gozzetti, A.; Aprile, L.; Chitarrelli, I.; Fabbri, A.; Lauria, F.; Bocchia, M. | - | |
| Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia | 1-gen-2010 | Gozzetti, A.; Crupi, R.; Rondoni, M.; Daviddi, B.; Defina, M.; Bocchia, M.; Pietrini, A.; Raspadori, D.; Lauria, F. | - | |
| Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib | 1-gen-2010 | Defina, M.; Gozzetti, A.; Rondoni, M.; Aprile, L.; Ippoliti, M.; Chitarrelli, I.; Lauria, F.; Bocchia, M. | - | |
| The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. | 1-gen-2009 | D., Rossi; M., Cerri; C., Deambrogi; E., Sozzi; S., Cresta; S., Rasi; L. D., Paoli; V., Spina; V., Gattei; D., Capello; Forconi, Francesco; Lauria, Francesco; G., Gaidano | - | |
| Combination therapies to improve the long-term outcome in hairy cell leukemia. | 1-gen-2009 | Lauria, Francesco; Forconi, Francesco | - | |
| Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. | 1-gen-2009 | Else, Monica; Dearden, Claire E.; Matutes, Estella; Garcia‐talavera, Juan; Rohatiner, Ama Z. S.; Johnson, Steve A. N.; O’Connor, Nigel T. J.; Haynes, Andy; Osuji, Nnenna; Forconi, Francesco; Lauria, Francesco; Catovsky, Daniel | - | |
| Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. | 1-gen-2009 | Forconi, Francesco; E., Sozzi; E., Cencini; F., Zaja; T., Intermesoli; C., Stelitano; L., Rigacci; F., Gherlinzoni; R., Cantaffa; A., Baraldi; A., Gallamini; A., Zaccaria; A., Pulsoni; M., Gobbi; M., Tassi; D., Raspadori; Leoncini, Lorenzo; A., Rinaldi; E., Sabattini; F., Bertoni; S. A., Pileri; Lauria, Francesco | - | |
| BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial | 1-gen-2009 | Bocchia, M.; Defina, M.; Ippoliti, M.; Amabile, M.; Breccia, M.; Iuliano, F.; Vignetti, M.; Gugliotta, G.; RUSSO ROSSI, A.; Alimena, A.; Aprile, L.; Gaidano, G.; Nicoli, N.; Trawinska, M. M.; Bassan, R.; Turri, D.; Cannella, L.; Luciano, L.; Gozzetti, A.; Rondoni, M.; Rosti, G.; Martinelli, G.; Baccarani, M.; Lauria, F. | - | |
| Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. | 1-gen-2008 | Forconi, F; Sozzi, E; Rossi, D; Sahota, S S; Amato, T; Raspadori, D; Trentin, L; Leoncini, L; Gaidano, G; Lauria, F | - | |
| High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia | 1-gen-2008 | Forconi, Francesco; Poretti, Giulia; Kwee, Ivo; Sozzi, Elisa; Rossi, Davide; Rancoita, Paola M. V.; Capello, Daniela; Rinaldi, Andrea; Zucca, Emanuele; Raspadori, Donatella; Spina, Valeria; Lauria, Francesco; Gaidano, Gianluca; Bertoni, Francesco | - | |
| CMLVAX100 Peptide Vaccinations induce Peptide Specific "cytotoxic" CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response | 1-gen-2008 | Bocchia, M.; Tassi, M.; Ippoliti, M.; Defina, M.; Abruzzese, E.; Trawinska, M. M.; Gozzetti, A.; Raspadori, D.; Lauria, F. | - | |
| Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases | 1-gen-2008 | Malagola, M; Peli, A; Damiani, D; Candoni, A; Tiribelli, M; Martinelli, G; Leoncini, L; Paolini, S; DE ROSA, Federica; Lauria, F.; Bocchia, M; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Priccolo, G; Gugliotta, L; Bonini, A; Visani, G; Skert, C; Bergonzi, C; Roccaro, Am; Filì, C; Fanin, R; Baccarani, M; Russo, D | - | |
| Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion | 1-gen-2008 | Forconi, Francesco; Rinaldi, Andrea; Kwee, Ivo; Sozzi, Elisa; Raspadori, Donatella; Rancoita, Paola M. V.; Scandurra, Marta; Rossi, Davide; Deambrogi, Clara; Capello, Daniela; Zucca, Emanuele; Marconi, Daniela; Bomben, Riccardo; Gattei, Valter; Lauria, Francesco; Gaidano, Gianluca; Bertoni, Francesco | - | |
| Reply to “Rituximab activity in CD20-positive multiple myeloma” | 1-gen-2008 | Gozzetti, Alessandro; Fabbri, Annalisa; Lazzi, Stefano; Bocchia, Monica; Lauria, Francesco | - | |
| Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia | 1-gen-2008 | Forconi, Francesco; Fabbri, Alberto; Lenoci, Mariapia; Sozzi, Elisa; Gozzetti, Alessandro; Tassi, Maristella; Raspadori, Donatella; Lauria, Francesco | - | |
| Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis | 1-gen-2008 | Cavazzini, Francesco; Hernandez, Jose Angel; Gozzetti, Alessandro; Russo Rossi, Antonella; De Angeli, Cristiano; Tiseo, Ruana; Bardi, Antonella; Tammiso, Elisa; Crupi, Rosaria; Lenoci, Maria Pia; Forconi, Francesco; Lauria, Francesco | - | |
| The effects of zoledronic acid on serum lipids in multiple myeloma patients | 1-gen-2008 | Gozzetti, A.; Gennari, L.; Merlotti, D.; Salvadori, S.; DE PAOLA, V.; Avanzati, A.; Franci, B.; Marchini, E.; Tozzi, M.; Campagna, M. S.; Nuti, R.; Lauria, F.; Martini, G. | - | |
| CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate | 1-gen-2008 | Bocchia, Monica; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pirrotta, Mt; Crupi, R; Tozzuoli, D; Trawinska, Mm; Defina, M; Martinelli, G; Lauria, Francesco | - | |
| Promyelocytic blast crisis of chronic myelogenous leukaemia during imatinib treatment. | 1-gen-2007 | Gozzetti, A; Bocchia, M; Calabrese, S; Pirrotta, M. T; Crupi, R; Raspadori, D; Lauria, F. | - | |
| Deletion 9q in a patient with concomitant myelodisplasia and non-Hodgkin lymphoma | 1-gen-2007 | Gozzetti, A.; Calabrese, S.; Crupi, R.; Tozzuoli, D.; Fabbri, A.; Bocchia, M.; Pirrotta, M. T.; Defina, M.; Lauria, F. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile